127 related articles for article (PubMed ID: 15870888)
21. The expression of metastasis suppressor MIM/MTSS1 is regulated by DNA methylation.
Utikal J; Gratchev A; Muller-Molinet I; Oerther S; Kzhyshkowska J; Arens N; Grobholz R; Kannookadan S; Goerdt S
Int J Cancer; 2006 Nov; 119(10):2287-93. PubMed ID: 16921485
[TBL] [Abstract][Full Text] [Related]
22. Mouse MIM, a tissue-specific regulator of cytoskeletal dynamics, interacts with ATP-actin monomers through its C-terminal WH2 domain.
Mattila PK; Salminen M; Yamashiro T; Lappalainen P
J Biol Chem; 2003 Mar; 278(10):8452-9. PubMed ID: 12482861
[TBL] [Abstract][Full Text] [Related]
23. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
24. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.
Ummanni R; Teller S; Junker H; Zimmermann U; Venz S; Scharf C; Giebel J; Walther R
FEBS J; 2008 Nov; 275(22):5703-13. PubMed ID: 18959755
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
[TBL] [Abstract][Full Text] [Related]
26. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.
Wang J; Thompson B; Ren C; Ittmann M; Kwabi-Addo B
Prostate; 2006 May; 66(6):613-24. PubMed ID: 16388505
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
Ifere GO; Barr E; Equan A; Gordon K; Singh UP; Chaudhary J; Igietseme JU; Ananaba GA
Cancer Detect Prev; 2009; 32(4):319-28. PubMed ID: 19186008
[TBL] [Abstract][Full Text] [Related]
28. Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.
Du P; Ye L; Ruge F; Yang Y; Jiang WG
Anticancer Res; 2011 Oct; 31(10):3205-12. PubMed ID: 21965727
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of matriptase by overexpression of bikunin attenuates cell invasion in prostate carcinoma cells.
Tsui KH; Chang PL; Feng TH; Chung LC; Hsu SY; Juang HH
Anticancer Res; 2008; 28(4A):1977-83. PubMed ID: 18649735
[TBL] [Abstract][Full Text] [Related]
30. AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts.
Zhang J; Park SI; Artime MC; Summy JM; Shah AN; Bomser JA; Dorfleutner A; Flynn DC; Gallick GE
J Clin Invest; 2007 Oct; 117(10):2962-73. PubMed ID: 17885682
[TBL] [Abstract][Full Text] [Related]
31. miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1.
Xu L; Zhong J; Guo B; Zhu Q; Liang H; Wen N; Yun W; Zhang L
Tumour Biol; 2016 Sep; 37(9):12023-12032. PubMed ID: 27164937
[TBL] [Abstract][Full Text] [Related]
32. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
33. Androgen dependent regulation of protein kinase A subunits in prostate cancer cells.
Kvissel AK; Ramberg H; Eide T; Svindland A; Skålhegg BS; Taskén KA
Cell Signal; 2007 Feb; 19(2):401-9. PubMed ID: 16949795
[TBL] [Abstract][Full Text] [Related]
34. Identification of palladin isoforms and characterization of an isoform-specific interaction between Lasp-1 and palladin.
Rachlin AS; Otey CA
J Cell Sci; 2006 Mar; 119(Pt 6):995-1004. PubMed ID: 16492705
[TBL] [Abstract][Full Text] [Related]
35. Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells.
Dubi N; Gheber L; Fishman D; Sekler I; Hershfinkel M
Carcinogenesis; 2008 Sep; 29(9):1692-700. PubMed ID: 18310092
[TBL] [Abstract][Full Text] [Related]
36. The role of KLF6 and its splice variants in cancer therapy.
DiFeo A; Martignetti JA; Narla G
Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
[TBL] [Abstract][Full Text] [Related]
37. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
38. [Effect of PC-1 gene expression on migration ability of prostate cancer cells].
Zhang H; Wan LC; Wang J; Zhou JG; Huang CF
Ai Zheng; 2005 Sep; 24(9):1043-7. PubMed ID: 16159422
[TBL] [Abstract][Full Text] [Related]
39. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
[TBL] [Abstract][Full Text] [Related]
40. Phospholipase-C gamma-1 (PLCgamma-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells.
Davies G; Martin TA; Ye L; Lewis-Russell JM; Mason MD; Jiang WG
Urol Oncol; 2008; 26(4):386-91. PubMed ID: 18367108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
